Monashee Investment Management’s ASLAN Pharmaceuticals ASLN Stock Holding History
Bought
Maintained
Sold
Other funds holding ASLN
ACM
Monashee Investment Management's ASLN Position: Q2 2021 in Review
Monashee Investment Management sold out of ASLAN Pharmaceuticals (ASLN) in Q2 2021, closing a stake of 10,500 shares — an estimated $1.41M sold.
Monashee Investment Management first reported a position in ASLN in Q1 2021 and held it in 1 quarter. The position peaked at $1.41M in Q1 2021. 31 funds tracked by Wall St. Rank hold ASLN as of Q2 2021.
- Monashee Investment Management reported no remaining ASLAN Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
- Monashee Investment Management sold 10,500 ASLAN Pharmaceuticals shares in Q2 2021, an estimated $1.41M.
- Monashee Investment Management first reported a position in ASLAN Pharmaceuticals in Q1 2021 and held it in 1 quarter.
- Monashee Investment Management's ASLAN Pharmaceuticals position peaked at $1.41M in Q1 2021.
- 31 funds tracked by Wall St. Rank held ASLAN Pharmaceuticals as of Q2 2021.
Based on Monashee Investment Management's 13F filing for Q2 2021, filed 12 Aug 2021.